Mondobiotech Holding Ag Basel (RLFTF)

$0.25 0.00 (0.80%)

15:59 EDT RLFTF Stock Quote Delayed 30 Minutes

What Will the Stock Market Do Today? 3 Big Stories to Watch.

By Sarah Smith, Editor, Today's Market Mar 29, 2021

So what will the stock market do today? It looks like investors will be waiting for updates on infrastructure spending and Archegos Capital.

RLFTF Stock: Why Relief Therapeutics and BRPA Stock Are Soaring Today

RLFTF: Why Little-Known Relief Therapeutics Is Climbing Today

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 1.46M

Day's Range 0.24 - 0.25

52-Week Range 0.14 - 0.95

Dividend & Yield N/A (N/A)

RLFTF Stock Predictions, Articles, and Mondobiotech Holding Ag Basel News

From the Web

Relief Therapeutics' Lead Candidate Gets US Orphan Drug Tag In Sarcoidosis

From Benzinga Aug 3, 2021

The FDA has granted Orphan Drug Designation to Relief Therapeutics Holding AG's (OTC: RLFTF) for RLF-100 (aviptadil), an inhaled formulation, for...

Relief Reports that its U.S. Collaboration Partner has Announced Emergency Use Authorization of Aviptadil in Nation of Georgia

From Relief Therapeutics Holdings AG Jul 28, 2021

GENEVA, SWITZERLAND / ACCESSWIRE / July 28, 2021 / RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) (" Relief "), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, reported today that the parent company of its collaboration partner, NRx Pharmaceuticals, Inc., (Nasdaq: NRXP) (" NRx ") reported in a press release yesterday that the Nation of Georgia's Prime Minister and

Review Of Present Therapies For Covid-19

From Talk Markets May 9, 2021

A summary of authorized drugs for Covid-19, those in development, and those that have failed.

Relief and AdVita Close Definitive Agreement for Relief to Acquire All Outstanding Shares of AdVita

From Relief Therapeutics Holdings AG Jul 28, 2021

Acquisition Expands Scope of Development of Inhaled Formulation of Aviptadil GENEVA, SWITZERLAND / ACCESSWIRE / July 28, 2021 / RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) (" Relief "), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, today announced that it has closed a definitive agreement to acquire all outstanding shares of AdVita Lifescience GmbH (" AdVita "),

Relief Therapeutics Announces CHF 15 Million Private Placement

From Relief Therapeutics Holdings AG Jul 26, 2021

GENEVA, SWITZERLAND / ACCESSWIRE / July 26, 2021 / RELIEF THERAPEUTICS Holding AG (SIX:RLF, OTCQB:RLFTF) (" Relief " or the " Company "), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, today announced that it has entered into a definitive agreement with two U.S. institutional investors to purchase in a private placement an aggregate of 71,428,572 shares of Relief common stock

Why NRX Pharmaceuticals (NRXP) Stock Is Moving Friday?

From Benzinga Jul 23, 2021

Extending yesterday's gain, NRx Pharmaceuticals Inc (NASDAQ: NRXP) stock is up more than 26% during the premarket trading on Friday. NRx's stock opened Thursday...